IFEX Drug Patent Profile
Which patents cover Ifex, and when can generic versions of Ifex launch?
Ifex is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in IFEX is ifosfamide; mesna. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IFEX?
- What are the global sales for IFEX?
- What is Average Wholesale Price for IFEX?
Summary for IFEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 107 |
| Patent Applications: | 4,724 |
| Drug Prices: | Drug price information for IFEX |
| What excipients (inactive ingredients) are in IFEX? | IFEX excipients list |
| DailyMed Link: | IFEX at DailyMed |
Pharmacology for IFEX
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
US Patents and Regulatory Information for IFEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-001 | Dec 30, 1988 | AP | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-004 | Oct 10, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-002 | Dec 30, 1988 | AP | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-003 | Oct 10, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IFEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-002 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-001 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-002 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | IFEX | ifosfamide | INJECTABLE;INJECTION | 019763-001 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IFEX
See the table below for patents covering IFEX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 274001 | ⤷ Start Trial | |
| Belgium | 700711 | ⤷ Start Trial | |
| Switzerland | 509353 | Verfahren zur Herstellung von neuen Phosphorsäure- und Thiophosphorsäurederivaten (Phosphoric and thiophosphoric acid ester amides with) | ⤷ Start Trial |
| Switzerland | 510699 | Verfahren zur Herstellung von neuen Phosphorsäure- und Thiophosphorsäurederivaten (Phosphoric and thiophosphoric acid ester amides with) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch